Answers are grounded in this paper and cite their sources.
Review highlights oxidized albumin's role as a biomarker for kidney disease, suggesting its clinical applications.
Oxidized albumin has emerged as a promising biomarker in blood for assessing oxidative stress and multiple organ dysfunction. Recent advances suggest its potential detectability in urine, offering a noninvasive avenue for early diagnosis and monitoring of kidney disease. This review synthesizes current knowledge on oxidized albumin, its pathophysiological relevance, and the evolving methodologies for its detection, highlighting its translational potential in clinical nephrology.
No takes yet. Share an insight, caveat, or question.
Shimosawa et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: